Beta-blockers curb death risk in high-risk STEMI patients

02/17/2013 | PhysiciansBriefing.com

A study in The American Journal of Cardiology found beta-blocker treatment may help cut long-term mortality in high-risk ST-segment elevation myocardial infarction patients. However, the therapy did not appear to benefit lower-risk patients, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN